![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
SWITCHING TO TAF IN EVG-BASED REGIMENS: CSF PHARMACOKINETICS AND ANTIVIRAL ACTIVITY
|
|
|
Poster pdf attached to see Table 1.
Download the PDF here
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Qing Ma1, Andrew J. Ocque1, Gene D. Morse1, Chelsea Sanders2, Alina Burgi2, Susan J. Little2, Scott L. Letendre2
1University at Buffalo, Buffalo, New York, USA; 2University of California San Diego, La Jolla, California, USA
![0530181](../images%20/053018/053018-5/0530181.gif)
![0530182](../images%20/053018/053018-5/0530182.gif)
![0530183](../images%20/053018/053018-5/0530183.gif)
![0530184](../images%20/053018/053018-5/0530184.gif)
![0530185](../images%20/053018/053018-5/0530185.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|